Dioscin-induced apoptosis of human LNCaP prostate carcinoma cells through activation of caspase-3 and modulation of Bcl-2 protein family

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 34, Issue 1, 2014, Pages 125-130

  Chen, Jing ^a   Li, Hui Min ^a,b   Zhang, Xue Nong ^c   Xiong, Chao Mei ^a   Ruan, Jin Lan ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b JIUJIANG UNIVERSITY   (China)

^c CHINA THREE GORGES UNIVERSITY   (China)

Author keywords

anti tumor; apoptosis pathway; Bcl 2 protein family; capsase 3; dioscin; LNCaP

Indexed keywords

CASPASE 3; DIOSCIN; DIOSGENIN; DRUG DERIVATIVE; PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL SURVIVAL; CHEMICAL STRUCTURE; CHEMISTRY; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR; TIME; TUMOR CELL LINE; WESTERN BLOTTING;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; DIOSGENIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMANS; MALE; MOLECULAR STRUCTURE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; TIME FACTORS;

EID: 84894047961     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-014-1243-y     Document Type: Article

References (38)

1. Carter HB, Coffey DS. The prostate: an increasing medical problem. Prostate, 1990,16(1):39-48
2. Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin, 2008,58(2):71-96
3. Swinnen JV, Heemers H, de Sande TV, et al. Androgens, lipogenesis and prostate cancer. J Steroid Biochem Mol Biol, 2004,92(4):273-279
4. Wigle DT, Turner MC, Gomes J, et al. Role of hormonal and other factors in human prostate cancer. J Toxicol Environ Health B Crit Rev, 2008,11(3-4):242-259
5. Joo SS, Yoo YM. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer. J Pineal Res, 2009,47(1): 8-14
6. Shaw GL, Wilson P, Cuzick J, et al. International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta-analysis of 1446 patients. BJU Int, 2007,99(5):1056-1065
7. Okada H, Mak TW. Pathways of apoptotic and non-apoptotic death in tumour cells. Nat Rev Cancer, 2004,4(8):592-603
8. Tang DG, Porter AT. Target to apoptosis: a hopeful weapon for prostate cancer. Prostate, 1997,32(4):284-293
9. Porter AG, Jänicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ, 1999,6(2):99-104
10. Liu DZ, Tian Z, Yan ZH, et al. Design, synthesis and evaluation of 1,2-benzisothiazol-3-one derivatives as potent caspase-3 inhibitors. Bioorg Med Chem, 2013,21(11): 2960-2967
11. Gross A. BCL-2 proteins: regulators of the mitochondrial apoptotic program. IUBMB Life, 2001,52(3-5):231-236
12. Adams JM, Cory S. The Bcl-2 protein family: arbiters of cell survival. Science, 1998,281(5381):1322-1326
13. O'Brien MA, Kirby R. Apoptosis: a review of pro-apoptotic and anti-apoptotic pathways and dysregulation in disease. J Vet Emerg Crit Car, 2008,18(6):572-585
14. Bush JA, Li G. The role of Bcl-2 family members in the progression of cutaneous melanoma. Clin Exp Metastas, 2001,20(6):531-539
15. Strasser A, Cory S, Adams JM. Deciphering the rules of programmed cell death to improve therapy of cancer and other diseases. EMBO J, 2011,30(18):3667-3683
16. Power C, Fanning N, Redmond HP. Cellular apoptosis and organ injury in sepsis: a review. Shock, 2002,18(3): 197-211
17. Del Poeta G, Venditti A, Del Principe MI, et al. Amount of spontaneous apoptosis detected by Bax/Bcl-2 ratio predicts outcome in acute myeloid leukemia (AML). Blood, 2003,101(6):2125-2131
18. Ho JW, Leung YK, Chan CP. Herbal medicine in the treatment of cancer. Curr Med Chem Anticancer Agents, 2002,2(2):209-214
19. D'Incalci M, Steward WP, Gescher AJ. Use of cancer chemopreventive phytochemicals as antineoplastic agents. Lancet Oncol, 2005,6(11):899-904
20. Sun WJ, Tu GZ, Zhang YM. A new steroidal saponin from Dioscorea zingiberensis Wright. Nat Prod Res, 2003,17(4):287-292
21. Xu Y, Wang HY, Jiang JY, et al. Studies on steroidal saponins from Smilax china and their cytotoxic activities. Chin J Exp Trad Med Form (Chinese), 2011,17(11):92-96
22. Wang LJ, Meng Q, Wang CY, et al. Dioscin restores the activity of the anticancer agent adriamycin in multidrug- resistant human leukemia K562/adriamycin cells by down-regulating MDR1 via a mechanism involving NF-κB signaling inhibition. J Nat Prod, 2013,76(5): 909-914
23. Liu CH, Wang Y, Wu CC, et al. Dioscin's antiviral effect in vitro. Virus Res, 2013,172(1-2):9-14
24. 4-induced liver damage in mice. Planta Med, 2011,77(5):407-415
25. Hu MM, Xu LN, Yin LH, et al. Cytotoxicity of dioscin in human gastric carcinoma cells through death receptor and mitochondrial pathways. J Appl Toxicol, 2013,33(8): 712-722
26. Mi QW, Lantvit D, Reyes-Lim E, et al. Evaluation of the potential cancer chemotherapeutic efficacy of natural product isolates employing in vivo hollow fiber tests. J Nat Prod, 2002,65(6):842-850
27. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods, 1983,65(1-2):55-63
28. Zhou YP. The calculation of LD50 in new drugs with software SPSS. Prog Pharm Sci (Chinese), 2003,27(5): 314-316
29. Sheppard BC, Rutten MJ, Meichsner GL, et al. Effects of paclitaxel on the growth of normal, polyposis, and cancerous human colonic epithelial cells. Cancer, 1999, 85(7):1454-1464
30. Cai J, Liu MJ, Wang Z, et al. Apoptosis induced by dioscin in hela cells. Biol Pharm Bull, 2002,25(2):193-196
31. Wang Z, Zhou JB, Ju Y, et al. Effects of two saponins extracted from the Polygonatum Zanlanscianense Pamp on the human leukemia (HL-60) cells. Biol Pharm Bull, 2001,24(2):159-162
32. Wang Y, Cheung YH, Yang ZQ, et al. Proteomic approach to study the cytotoxicity of dioscin (saponin). Proteomics, 2006,6(8):2422-2432
33. Wang ZY, Cheng Y, Wang N, et al. Dioscin induces cancer cell apoptosis through elevated oxidative stress mediated by downregulation of peroxiredoxins. Cancer Biol Ther, 2012,13(3):138-147
34. Golbano JM, López-Aparicio P, Recio MN, et al. Finasteride induces apoptosis via Bcl-2, Bcl-xL, Bax and caspase-3 proteins in LNCaP human prostate cancer cell line. Int J Oncol, 2008,32(4): 919-924
35. Ashe PC, Berry MD. Apoptotic signaling cascades. Prog Neuro-psychopharmacol Biol Psychiatry, 2003,27(2): 199-214
36. Saraste A, Pulkki K. Morphologic and biochemical hallmarks of apoptosis. Cardiovasc Res, 2000,45(3):528-537
37. Cory S, Adams JM. The Bcl2 family: Regulators of the cellular life-or-death switch. Nat Rev Cancer, 2002,2(9): 647-656
38. Kim MO, Moon DO, Kang CH, et al. Water-soluble chitosan sensitizes apoptosis in human leukemia cells via the downregulation of bcl-2 and dephosphorylation of AKT. J Food Biochem, 2013,37(3):270-277